» Authors » Anna Bianchi

Anna Bianchi

Explore the profile of Anna Bianchi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 84
Citations 989
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Marzola E, Melloni L, Caligiure A, Gianessi F, Bianchi A, Borghi A, et al.
Contact Dermatitis . 2024 Jul; 91(5):434-436. PMID: 38963233
No abstract available.
2.
Srinivasan S, Mehra S, Bianchi A, Singh S, Dosch A, Amirian H, et al.
bioRxiv . 2024 Jun; PMID: 38903082
Background And Aims: induction of alcoholic chronic pancreatitis (ACP) causes significant acinar damage, increased fibroinflammatory response, and heightened activation of cyclic response element binding protein 1 (CREB) when compared with...
3.
Lerin L, Botti G, Dalpiaz A, Bianchi A, Ferraro L, Chaibi C, et al.
Int J Mol Sci . 2024 Jun; 25(11). PMID: 38892454
Ferulic acid (Fer) and geraniol (Ger) are natural compounds whose antioxidant and anti-inflammatory activity confer beneficial properties, such as antibacterial, anticancer, and neuroprotective effects. However, the short half-lives of these...
4.
Deshpande N, Bianchi A, Amirian H, De Castro Silva I, Rafie C, Surnar B, et al.
bioRxiv . 2024 Jun; PMID: 38854120
Pancreatic ductal adenocarcinoma (PDAC) is characterized by intratumoral abundance of neutrophilic/polymorphonuclear myeloid-derived suppressor cells (PMN-MDSC) which inhibit T-cell function through JAK2/STAT3-regulated arginase activity. To overcome limitations of systemic inhibition of...
5.
Dickey E, Bianchi A, Amirian H, Hosein P, Faustman D, Brambilla R, et al.
Oncoimmunology . 2024 Mar; 13(1):2326694. PMID: 38481728
Pancreatic cancer is characterized by extreme therapeutic resistance. In pancreatic cancers harboring high-risk genomes, we describe that cancer cell-neutrophil signaling circuitry provokes neutrophil-derived transmembrane (tm)TNF-TNFR2 interactions that dictate inflammatory polarization...
6.
Corazza M, Catani M, Franchina F, Cavazzini A, Bianchi A, Borghi A, et al.
Dermatitis . 2024 Mar; 35(6):657-659. PMID: 38447127
No abstract available.
7.
Singh S, Dosch A, Mehra S, De Castro Silva I, Bianchi A, Garrido V, et al.
Cancer Res . 2024 Jan; 84(8):1320-1332. PMID: 38285896
Significance: Inhibition of p38 MAPK suppresses tumor cell-derived IL1α and attenuates the inflammatory stroma and immunosuppressive tumor microenvironment to overcome chemotherapeutic resistance in pancreatic cancer.
8.
Corazza M, Arlotti E, Schettini N, Pacetti L, Bianchi A, Borghi A
Ital J Dermatol Venerol . 2023 Nov; 159(1):72-74. PMID: 38015572
No abstract available.
9.
Botti G, Bianchi A, Dalpiaz A, Tedeschi P, Albanese V, Sorrenti M, et al.
Expert Opin Drug Deliv . 2023 Nov; 20(11):1657-1679. PMID: 38014509
Objective: Ferulic acid (Fer) displays antioxidant/anti-inflammatory properties useful against neurodegenerative diseases. To increase Fer uptake and its central nervous system residence time, a dimeric prodrug, optimizing the Fer loading on...
10.
Selva A, Bianchi A, Bellan L, Fagotti E, Pisent A, Conte V
Radiat Prot Dosimetry . 2023 Oct; 199(15-16):1963-1967. PMID: 37819342
In the framework of the MUNES project, a prototype accelerator-based thermal neutron source was developed and installed at the Legnaro National Laboratories of INFN. The microdosimetric characterization of this radiation...